Intelligene stands as one of the pioneering drug development companies in Taiwan's biotechnology sector. We are at the forefront of advancing gene therapeutics through siRNA-based drugs, utilizing a revolutionary approach that harnesses the power of RNA interference technology to combat formidable adversaries. Our mission is to confront the looming threats of pandemics and influenza. Our dedicated team of scientists and researchers is united by a shared purpose: to safeguard and improve human well-being by developing innovative solutions. These solutions not only address the immediate challenges posed by infectious diseases but also hold the promise of a healthier future.
-
Dr. Tom LinExperience
Dr. Tom Lin (Yu-Hsin Lin) is the Founder, Chairman, and Chief Executive Officer of Belite Bio. Dr. Lin is also the Founder of Lin BioScience, Inc. (TPEx 6696.) Prior
to founding Belite Bio, Dr. Lin was executive officer of several biotech companies, including Lin Bio Science, Inc. Dr. Lin received his master degree in Medicine
and PhD in Medicine from University of Sydney, and his MBA from Columbia University, London Business School, and University of Hong Kong.
MORE
Experience
Dr. Tom Lin (Yu-Hsin Lin) is the Founder, Chairman, and Chief Executive Officer of Belite Bio. Dr. Lin is also the Founder of Lin BioScience, Inc. (TPEx 6696.) Prior
to founding Belite Bio, Dr. Lin was executive officer of several biotech companies, including Lin Bio Science, Inc. Dr. Lin received his master degree in Medicine
and PhD in Medicine from University of Sydney, and his MBA from Columbia University, London Business School, and University of Hong Kong.
